<unk> (recombinant) is an Antihemophilic Agent that is FDA approved for the prevention of of bleeding episodes in adults and children (0-16 years) with Hemophilia A, Perioperative management in adults and children (0-16 years) with Hemophilia A and indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children (0-16 years) with Hemophilia A.   Common adverse reactions include arthralgia, headache, cough, nasopharyngitis, fever, anaphylaxis, and hypersensitivity reaction..
Antihemophilic Factor 
Antihemophilic factor
Antihemophilic factor 
Lupus anticoagulant
Antithrombin III
Factor ix complex
Immunoglobulin E
Thrombus precursor protein 